Studi Collaborativi
1. The PLATO Collaboration. Predictors of CD4 count trend and mortality among HIV-1 infected persons with virologic failure to all three antiretroviral drug classes. The Lancet 2004; 364:51-62.
2. Collaboration of HIV Cohorts. Nucleoside analogue use before and during highly active antiretroviral therapy and virus load rebound.The Journal of Infectious Diseases 2004; 190:675-687.
3. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group. Response to combination antiretroviral therapy: variation by age. AIDS. 2008 Jul 31;22(12):1463-73.
4. Collaboration of MASTER Cohort and ARCA Cohort.Effectiveness of Antiretroviral Regimens Containing Abacavir with Tenofovir in Treatment-Experienced Patients: Predictors of Virological Response and Drug Resistance Evolution in a Multi-Cohort Study. Infection. 2009 Aug 7.
5. The PLATO II Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group Triple class virologic failure in HIV-infected patients on antiretroviral therapy for up to 10 years Archives of Internal Medicine 2010 Mar 8;170(5):410-419.
6. European multicohort study. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a Lancet Infect Dis. 2011 Feb 25.
7. The MASTER, Chelsea & Westminster, ICONA, Modena and S. Raffaele HIV Cohorts Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI. BMC Infect Dis. 2011 Jan 25;11(1):23.
8. Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL? Infect Dis. 2010 Sep 1;51(5):611-9. Erratum in: Clin Infect Dis. 2010 Nov 1;51(9):1114.
9. (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. Pursuing Later Treatment Options II, Arch Intern Med. 2010 Mar 8;170(5):410-9
10. UCSC cohort; MASTER cohort; ARCA cohort. Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study. Infection. 2009 Oct;37(5):438-44.